757 results on '"Harjola, Veli-Pekka"'
Search Results
202. Ventricular conduction abnormalities as predictors of long‐term survival in acute de novo and decompensated chronic heart failure
203. Les défauts de la conduction ventriculaire dans le choc cardiogénique
204. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort
205. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.
206. Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry.
207. Rapid cardiothoracic ultrasound protocol for diagnosis of acute heart failure in the emergency department
208. Editor’s Choice-The role of the emergency department in the management of acute heart failure: An international perspective on education and research
209. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine – short version
210. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergenc
211. Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy
212. Acute Heart Failure With and Without Concomitant Acute Coronary Syndromes: Patient Characteristics, Management, and Survival
213. Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation
214. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
215. Acute Heart Failure.
216. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
217. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.
218. IMPROV-ED study: outcomes after discharge for an episode of acute-decompensated heart failure and comparison between patients discharged from the emergency department and hospital wards.
219. Triage quality control is missing tools-a new observation technique for ED quality improvement.
220. Disposition of emergency department patients diagnosed with acute heart failure: an international emergency medicine perspective.
221. Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock.
222. The type of acute heart failure and the costs of hospitalization
223. Emergency Medicine in Finland: First Year Experiences of Specialist Training
224. Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
225. High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation
226. Response to Letter Regarding Article, “Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation”
227. High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
228. Assessment of early treatment response by rapid cardiothoracic ultrasound in acute heart failure: Cardiac filling pressures, pulmonary congestion and mortality
229. Altered mental status predicts mortality in cardiogenic shock – results from the CardShock study
230. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium
231. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study
232. Long-term survival after hospitalization for acute heart failure — Differences in prognosis of acutely decompensated chronic and new-onset acute heart failure
233. Renal Effects of Levosimendan: A Consensus Report
234. Critically ill patients in emergency department may be characterized by low amplitude and high variability of amplitude of pulse photoplethysmography
235. Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
236. Association Between Elevated Blood Glucose and Outcome in Acute Heart Failure
237. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
238. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
239. N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography.
240. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
241. The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure
242. Editor’s Choice-The role of the emergency department in the management of acute heart failure: An international perspective on education and research
243. International Perspectives on Emergency Department Crowding
244. Cystatin C: a step forward in assessing kidney function and cardiovascular risk
245. Oral levosimendan improves filling pressure and systolic function during long-term treatment
246. Reduction in membrane component of diffusing capacity is associated with the extent of acute pulmonary embolism
247. Clinical significance of cardiac troponins I and T in acute heart failure
248. Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure
249. Heart failure in the elderly: How risky is it to be discharged?
250. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.